M Mudoola

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

James Hakim, Cissy Kityo, Anne Hoppé et al. · The Lancet Infectious Diseases · 2017 · 41 citations · Full text

Pharmacy, Infectious Disease Control, Pharmacotherapy +17

Preventing neonatal sepsis in rural Uganda: a cross-over study comparing the tolerance and acceptability of three alcohol-based hand rub formulations

James Ditai, M Mudoola, Melissa Gladstone et al. · BMC Public Health · 2018 · 14 citations · Full text

Public Health, Maternal Health, Breastfeeding +9

BabyGel pilot: a pilot cluster randomised trial of the provision of alcohol handgel to postpartum mothers to prevent neonatal and young infant infection-related morbidity in the community

James Ditai, Julian Abeso, N. Odeke et al. · Pilot and Feasibility Studies · 2019 · 14 citations · Full text

Public Health, Community Health, Maternal Health +17

Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial

Cissy Kityo, David Dunn, Anne Hoppé et al. · Clinical Infectious Diseases · 2018 · 12 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Identifying women giving birth preterm and care at the time of birth: a prospective audit of births at six hospitals in India, Kenya, Pakistan and Uganda

Eleanor Mitchell, Santosh Benjamin, Sam Ononge et al. · BMC Pregnancy and Childbirth · 2020 · 12 citations · Full text

Medicine, Maternal Health, Obstetrics +17